Lucid Diagnostics Collaborates with the University of Pennsylvania to Evaluate EsoCheck in Patients with Eosinophilic Esophagitis

Lucid Diagnostics Collaborates with University of Pennsylvania to Evaluate EsoCheck in Patients with Eosinophilic Esophagitis

Shots:

  • The Lucid-Penn agreement will evaluate Lucid’s EsoCheck esophageal cell collection device with Collect+Protect technology as a less invasive, more efficient, and cost-effective alternative to endoscopic biopsies to manage patients with EoE
  • The study will assess 10 patients with suspected or established EoE scheduled for a clinically indicated upper endoscopy which will undergo esophageal sampling using EsoCheck followed by endoscopy including brushings and biopsies
  • EsoCheck is an FDA 510(k)-cleared non-invasive device designed to sample cells from a targeted region of the esophagus in a five-minute office-based procedure, without the need for endoscopy

Click here ­to­ read full press release/ article | Ref: GlobeNewswire | Image: Pavmed